1. 127. Development of a Kinetic ELISA (kELISA) and Reactive B-cell Frequency (RBF) Assay to Detect Respiratory Syncytial Virus (RSV) Pre-Fusion F Protein-Specific Immune Responses in Infants. (4th December 2021) Authors: Rolsma, Stephanie L; Yoder, Sandy M; Nargi, Rachel S; Brady, Eric; Jimenez-Truque, Natalia; Thomsen, Isaac; Thompson, Marissa; Carnahan, Robert H; Sutton, Rachel E; Armstrong, Erica; Dally, Len; Crowe, James E; Edwards, Kathryn M; Creech, Buddy Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase I randomized, double‐blind, single subcutaneous dose escalation study to determine the safety, tolerability, and pharmacokinetics of rezafungin in healthy adult subjects. Issue 7 (4th May 2022) Authors: Gu, Kenan; Ruff, Dennis; Key, Cassandra; Thompson, Marissa; Jiang, Shoshanna; Sandison, Taylor; Flanagan, Shawn Journal: Clinical and translational science Issue: Volume 15:Issue 7(2022) Page Start: 1592 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗